Factors influencing enrollment in clinical trials for cancer treatment
- PMID: 10624912
- DOI: 10.1097/00007611-199912000-00011
Factors influencing enrollment in clinical trials for cancer treatment
Abstract
Background: Recruitment of cancer patients to clinical trials is an ongoing challenge. In this study, we assess factors that may influence enrollment in clinical trials for cancer treatment.
Methods: Between June 1997 and January 1998, data were collected on all adult cancer patients evaluated for enrollment in National Cancer Institute-sponsored clinical trials at 15 medical facilities in the southeastern United States.
Results: More than 2,300 cancer patients were evaluated; 7% were enrolled. Neither patient sex nor race predicted enrollment. Patients with fee-for-service coverage were more than twice as likely to be enrolled compared with patients with other types of coverage, including managed care. Patient refusal accounted for the nonenrollment of nearly 40% of those clinically eligible.
Conclusions: Although multiple factors influence enrollment in clinical trials for cancer treatment, results suggest that insurance coverage plays a role. Patient refusal, a substantial reason for nonenrollment, points to the need for continued efforts to educate physicians and the public in the value of clinical trials.
Similar articles
-
Barriers to clinical trial enrollment: are state mandates the solution?J Natl Cancer Inst. 2004 Jul 21;96(14):1048-9. doi: 10.1093/jnci/djh225. J Natl Cancer Inst. 2004. PMID: 15265958 No abstract available.
-
Cancer trial enrollment after state-mandated reimbursement.J Natl Cancer Inst. 2004 Jul 21;96(14):1063-9. doi: 10.1093/jnci/djh193. J Natl Cancer Inst. 2004. PMID: 15265967
-
Cancer patient care in clinical trials sponsored by the National Cancer Institute: what does it cost?J Natl Cancer Inst. 1999 May 19;91(10):818-9. doi: 10.1093/jnci/91.10.818. J Natl Cancer Inst. 1999. PMID: 10340896 No abstract available.
-
Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.J Natl Cancer Inst Monogr. 1998;(24):1-28. J Natl Cancer Inst Monogr. 1998. PMID: 9704318 Review. No abstract available.
-
Evaluating cancer costs in NCI trials.Cancer Treat Res. 1998;97:37-52. doi: 10.1007/978-0-585-30498-4_4. Cancer Treat Res. 1998. PMID: 9711408 Review.
Cited by
-
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis.Cancer Control. 2022 Jan-Dec;29:10732748221130164. doi: 10.1177/10732748221130164. Cancer Control. 2022. PMID: 36165718 Free PMC article.
-
A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).Oncologist. 2012;17(9):1180-90. doi: 10.1634/theoncologist.2011-0384. Epub 2012 Jun 20. Oncologist. 2012. PMID: 22723506 Free PMC article.
-
Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.Contemp Clin Trials. 2012 Sep;33(5):933-41. doi: 10.1016/j.cct.2012.06.001. Epub 2012 Jun 8. Contemp Clin Trials. 2012. PMID: 22683991 Free PMC article.
-
The motivation of breast cancer patients to participate in a national randomized control trial.Support Care Cancer. 2023 Jul 15;31(8):468. doi: 10.1007/s00520-023-07930-0. Support Care Cancer. 2023. PMID: 37452876 Free PMC article. Clinical Trial.
-
Comparison of survival outcomes among cancer patients treated in and out of clinical trials.J Natl Cancer Inst. 2014 Mar;106(3):dju002. doi: 10.1093/jnci/dju002. Epub 2014 Mar 13. J Natl Cancer Inst. 2014. PMID: 24627276 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical